Eurofins Central Laboratory

Eurofins Central Laboratory: Disrupting Clinical Trials with Cutting-Edge Analytical Services

Founded in 1987, Eurofins Central Laboratory has emerged as a pioneering force in the health care industry. The company's dedication to providing standardized, high-quality global central laboratory services for all stages of clinical trials speaks volumes about its commitment to excellence.

With 25+ years of experience and a robust scientific background, Eurofins Central Laboratory has established a global presence with 4 wholly-owned and harmonized laboratory facilities located in the US, Europe, Singapore, and China. Its comprehensive laboratory testing portfolio covers integrated safety assessment, exploratory biomarkers, end point biomarkers, biomarker development, therapeutic drug monitoring, genomic testing, and a range of services supporting vaccine development.

The company's slogan, "Your Go-To Laboratory CRO for Global Analytical Services & End-to-End Integrated Lab Performance," embodies its mission to provide the highest quality central laboratory services. Eurofins Central Laboratory's commitment to delivering accurate, timely results within the planned completion dates is reinforced by its team of highly qualified and experienced scientists, ensuring expert advice and reliable services for its customers.

With no recent investment information available, Eurofins Central Laboratory's track record and industry positioning make it an intriguing candidate for potential venture capital interest, offering an opportunity to partner with a firm at the forefront of advancing analytical services in clinical trials.